Population structure of Helicobacter pylori and antibiotic resistance-associated variants in a high-risk area of gastric cancer.

IF 6.1 2区 医学 Q1 MICROBIOLOGY
Journal of Clinical Microbiology Pub Date : 2025-05-14 Epub Date: 2025-04-11 DOI:10.1128/jcm.00033-25
Qiu-Yu Jin, Roberto C Torres, Chao Yang, Li-Hua He, Zong-Chao Liu, Wen-Qing Li, Wei-Dong Liu, Lan-Fu Zhang, Daniel Falush, Yang Zhang, Kai-Feng Pan
{"title":"Population structure of <i>Helicobacter pylori</i> and antibiotic resistance-associated variants in a high-risk area of gastric cancer.","authors":"Qiu-Yu Jin, Roberto C Torres, Chao Yang, Li-Hua He, Zong-Chao Liu, Wen-Qing Li, Wei-Dong Liu, Lan-Fu Zhang, Daniel Falush, Yang Zhang, Kai-Feng Pan","doi":"10.1128/jcm.00033-25","DOIUrl":null,"url":null,"abstract":"<p><p>The increasing antibiotic resistance of <i>Helicobacter pylori</i> has had a serious impact on gastric cancer prevention. Our study aimed to profile the genomic characteristics and explore variants associated with resistance in <i>H. pylori</i> strains from a high-risk area of gastric cancer in China. We isolated 153 strains from a community-based cohort and assessed their susceptibility to six antibiotics by MIC Test Strip and genomic characteristics by whole-genome sequencing. Phylogenetic analysis identified the strains as an independent cluster within <i>H. pylori</i> East Asian population (hpEastAsia). <i>HefA</i>, an efflux pump gene, showed the highest differentiation in the Linqu strains compared with the other Chinese strains. Bacterial genome-wide association study (GWAS) identified 86 resistance variants covering 44 genes. Novel resistance variants were found in <i>lon</i> and <i>babA</i> for metronidazole, <i>HP1168</i> for clarithromycin, <i>hcpC</i> for levofloxacin, and <i>sabA</i> for rifamycin. Two newly identified <i>hefA</i> mutations (R229K and A283V) showed significant associations with metronidazole (<i>P</i> = 0.012) and tetracycline (<i>P</i> = 0.044) resistance, respectively. <i>HefA</i> mutations and GWAS variants were integrated with the significant literature-reported mutations to optimize the prediction models for metronidazole, levofloxacin, clarithromycin, and tetracycline resistance with area under the receiver operating characteristic curves of 0.82-0.93. Double-antibiotic resistance models were established for clinical applicability. Furthermore, <i>hefA</i> expression may play a potential mediating role in the associations between mutations and resistance. This study identified genetic independence in the representative <i>H. pylori</i> strains from a high-risk area of gastric cancer. Optimized resistance prediction panels, including novel <i>hefA</i> mutations and GWAS variants, may provide preliminary guidance for localized precise treatment and helpful experiences for the similar high-risk populations.IMPORTANCE<i>Helicobacter pylori</i> is a remarkable pathogen due to its virulence in gastric cancer and high genetic plasticity. Linqu County in China, a high-risk area of gastric cancer, faces serious antibiotic resistance issues and necessitates genomic profiling of local <i>H. pylori</i> strains. Phylogenetic analysis revealed the Linqu strains as a relatively independent cluster within the hpEastAsia population. Novel antibiotic resistance-associated <i>hefA</i> mutations and variants from our bacterial genome-wide association study in the Linqu strains were optimized to improve the prediction performances for single antibiotic and double-drug combination resistance compared with traditional literature-reported mutations. This study identified relative genetic independence and high differentiation in the representative <i>H. pylori</i> strains from a population with high risk of gastric cancer and high prevalence of antibiotic resistance. The optimized panels with novel variants improve antibiotic resistance prediction models compared with literature-reported mutations, providing guidance for localized precise treatment and suggesting prevention strategies for similar high-risk populations.</p>","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":"63 5","pages":"e0003325"},"PeriodicalIF":6.1000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077087/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/jcm.00033-25","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The increasing antibiotic resistance of Helicobacter pylori has had a serious impact on gastric cancer prevention. Our study aimed to profile the genomic characteristics and explore variants associated with resistance in H. pylori strains from a high-risk area of gastric cancer in China. We isolated 153 strains from a community-based cohort and assessed their susceptibility to six antibiotics by MIC Test Strip and genomic characteristics by whole-genome sequencing. Phylogenetic analysis identified the strains as an independent cluster within H. pylori East Asian population (hpEastAsia). HefA, an efflux pump gene, showed the highest differentiation in the Linqu strains compared with the other Chinese strains. Bacterial genome-wide association study (GWAS) identified 86 resistance variants covering 44 genes. Novel resistance variants were found in lon and babA for metronidazole, HP1168 for clarithromycin, hcpC for levofloxacin, and sabA for rifamycin. Two newly identified hefA mutations (R229K and A283V) showed significant associations with metronidazole (P = 0.012) and tetracycline (P = 0.044) resistance, respectively. HefA mutations and GWAS variants were integrated with the significant literature-reported mutations to optimize the prediction models for metronidazole, levofloxacin, clarithromycin, and tetracycline resistance with area under the receiver operating characteristic curves of 0.82-0.93. Double-antibiotic resistance models were established for clinical applicability. Furthermore, hefA expression may play a potential mediating role in the associations between mutations and resistance. This study identified genetic independence in the representative H. pylori strains from a high-risk area of gastric cancer. Optimized resistance prediction panels, including novel hefA mutations and GWAS variants, may provide preliminary guidance for localized precise treatment and helpful experiences for the similar high-risk populations.IMPORTANCEHelicobacter pylori is a remarkable pathogen due to its virulence in gastric cancer and high genetic plasticity. Linqu County in China, a high-risk area of gastric cancer, faces serious antibiotic resistance issues and necessitates genomic profiling of local H. pylori strains. Phylogenetic analysis revealed the Linqu strains as a relatively independent cluster within the hpEastAsia population. Novel antibiotic resistance-associated hefA mutations and variants from our bacterial genome-wide association study in the Linqu strains were optimized to improve the prediction performances for single antibiotic and double-drug combination resistance compared with traditional literature-reported mutations. This study identified relative genetic independence and high differentiation in the representative H. pylori strains from a population with high risk of gastric cancer and high prevalence of antibiotic resistance. The optimized panels with novel variants improve antibiotic resistance prediction models compared with literature-reported mutations, providing guidance for localized precise treatment and suggesting prevention strategies for similar high-risk populations.

胃癌高危区幽门螺杆菌种群结构及抗生素耐药性相关变异
幽门螺杆菌对抗生素的耐药性日益增强,对胃癌的预防产生了严重影响。本研究旨在分析中国胃癌高危地区幽门螺杆菌菌株的基因组特征并探索与耐药相关的变异。我们从社区队列中分离了153株菌株,并通过MIC试纸和全基因组测序评估了它们对6种抗生素的敏感性。系统发育分析表明该菌株为幽门螺旋杆菌东亚种群(hpEastAsia)中的一个独立聚类。外排泵基因HefA在临朐菌株中分化程度最高。细菌全基因组关联研究(GWAS)鉴定出86个耐药变异,涵盖44个基因。lon和babA对甲硝唑、HP1168对克拉霉素、hcpC对左氧氟沙星、sabA对利福霉素均有新的耐药变异。两个新发现的hefA突变(R229K和A283V)分别与甲硝唑(P = 0.012)和四环素(P = 0.044)耐药性显著相关。将HefA突变和GWAS突变与文献报道的显著突变相结合,优化甲硝唑、左氧氟沙星、克拉霉素和四环素耐药预测模型,其受试者工作特征曲线下面积为0.82 ~ 0.93。建立双抗生素耐药模型以供临床应用。此外,hefA表达可能在突变和耐药性之间的关联中发挥潜在的中介作用。本研究鉴定了来自胃癌高危区具有代表性的幽门螺杆菌菌株的遗传独立性。优化的耐药预测面板,包括新的hefA突变和GWAS变异,可能为局部精确治疗提供初步指导,并为类似的高危人群提供有益的经验。幽门螺杆菌因其在胃癌中的毒力和高度的遗传可塑性而成为一种引人注目的病原体。中国临朐县是胃癌高发地区,面临严重的抗生素耐药问题,有必要对当地的幽门螺杆菌进行基因组分析。系统发育分析表明,临朐菌株是hpEastAsia居群中一个相对独立的聚类。与传统文献报道的突变相比,我们对临朐菌株中与抗生素耐药相关的新型hefA突变和变异进行了优化,以提高对单药和双药联合耐药的预测能力。本研究从胃癌高风险和抗生素耐药性高流行的人群中鉴定出具有代表性的幽门螺杆菌菌株的相对遗传独立性和高度分化。与文献报道的突变相比,具有新变异的优化面板改进了抗生素耐药性预测模型,为局部精确治疗提供指导,并为类似高危人群提供预防策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Microbiology
Journal of Clinical Microbiology 医学-微生物学
CiteScore
17.10
自引率
4.30%
发文量
347
审稿时长
3 months
期刊介绍: The Journal of Clinical Microbiology® disseminates the latest research concerning the laboratory diagnosis of human and animal infections, along with the laboratory's role in epidemiology and the management of infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信